(Q41611587)

5 October 2017

1 reference

title

Diagnosis and management of steroid-resistant asthma (English)

1 reference

5 October 2017

Leung DY

1

1 reference

PubMed ID

9329880

5 October 2017

Szefler SJ

series ordinal

2

1 reference

5 October 2017

1 September 1997

1 reference

Clinics in Chest Medicine

5 October 2017

1 reference

5 October 2017

18

1 reference

5 October 2017

3

1 reference

5 October 2017

611-625

1 reference

Inflammatory cells and eosinophilic activity in asthmatics investigated by bronchoalveolar lavage. The effects of antiasthmatic treatment with budesonide or terbutaline

5 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Trial of cyclosporin in corticosteroid-dependent chronic severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Steroid-resistant asthma: immunologic and pharmacologic features

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

An open study of auranofin in the treatment of steroid-dependent asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

In-vitro glucocorticoid studies for predicting response to glucocorticoid therapy in adults with malignant lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Eosinophilic Inflammation in Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Primary cortisol resistance in man. A glucocorticoid receptor-mediated disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Comparative effects of inhaled salbutamol, sodium cromoglycate, and beclomethasone dipropionate on allergen-induced early asthmatic responses, late asthmatic responses, and increased bronchial responsiveness to histamine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Glucocorticoid resistance in chronic asthma. Glucocorticoid pharmacokinetics, glucocorticoid receptor characteristics, and inhibition of peripheral blood T cell proliferation by glucocorticoids in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Glucocorticoid resistance in chronic asthma. Peripheral blood T lymphocyte activation and comparison of the T lymphocyte inhibitory effects of glucocorticoids and cyclosporin A.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Steroid-resistant bullous pemphigoid treated with cyclosporin A.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Twenty-four hour lung function in adult patients with asthma. Chronoptimized theophylline therapy once-daily dosing in the evening versus conventional twice-daily dosing.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Transcription factor interactions: selectors of positive or negative regulation from a single DNA element.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Effect of an inhaled corticosteroid on airway inflammation and symptoms in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Cyclosporin in Steroid-Resistant Auto-Immune Haemolytic Anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Inhaled corticosteroids reduce the severity of bronchial hyperresponsiveness in asthma but oral theophylline does not.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Successful treatment of life-threatening steroid-resistant pulmonary sarcoidosis with cyclosporin in a patient with systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Monitoring glucocorticoid therapy: a pharmacokinetic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Primary structure and expression of a functional human glucocorticoid receptor cDNA

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Point mutation causing a single amino acid substitution in the hormone binding domain of the glucocorticoid receptor in familial glucocorticoid resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Nuclear factor of activated T cells contains Fos and Jun.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Pharmacodynamics and pharmacokinetics of inhaled glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

High-dose systemic glucocorticoid therapy in the treatment of severe asthma: a case of resistance and patterns of response

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Coexistence of glucocorticoid receptor and pharmacokinetic abnormalities: factors that contribute to a poor response to treatment with glucocorticoids in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Asthma and inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Cytokines of the lung

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Effect of long-term treatment with inhaled corticosteroids and beta-agonists on the bronchial responsiveness in children with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Are theophylline "levels" a reliable indicator of compliance?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Effects of glucocorticoids on lymphocyte activation in patients with steroid-sensitive and steroid-resistant asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Glucocorticoid receptor characteristics in monocytes of patients with corticosteroid-resistant bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Chemical mutational analysis of the human glucocorticoid receptor cDNA in glucocorticoid-resistant bronchial asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Dysregulation of interleukin 4, interleukin 5, and interferon gamma gene expression in steroid-resistant asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Abnormal glucocorticoid receptor gene and mRNA in primary cortisol resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Protective effects of a glucocorticoid on downregulation of pulmonary beta 2-adrenergic receptors in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Circadian variations in theophylline concentrations and the treatment of nocturnal asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Methotrexate in the treatment of corticosteroid-dependent asthma. A double-blind crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

The frequency and severity of cat allergy vs. dog allergy in atopic children

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Budesonide treatment of moderate and severe asthma in children: a dose-response study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Resistance to methylprednisolone in cultures of blood mononuclear cells from glucocorticoid-resistant asthmatic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Prednisolone treatment in asthma is associated with modulation of bronchoalveolar lavage cell interleukin-4, interleukin-5, and interferon-gamma cytokine gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Steroid Resistance in Bronchial Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Steroid-resistant asthma. Cellular mechanisms contributing to inadequate response to glucocorticoid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Randomised, double-blind, placebo-controlled trial of methotrexate in steroid-dependent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Reduced glucocorticoid binding affinity in asthma is related to ongoing allergic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Anti-inflammatory drugs in the treatment of allergic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Effect of corticosteroid treatment on interleukin-1 and tumour necrosis factor secretion by monocytes from subjects with asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Identification and characterization of a monocyte-derived neutrophil-activating factor in corticosteroid-resistant bronchial asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

Glucocorticoid inhibition of interleukin-1-induced interleukin-6 production by human lung fibroblasts: evidence for transcriptional and post-transcriptional regulatory mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0272-5231%2805%2970405-6

7 January 2021

10.1016/S0272-5231(05)70405-6

Identifiers

DOI

1 reference

5 October 2017

1 reference

PubMed ID

9329880